scispace - formally typeset
I

Itai Danovitch

Researcher at Cedars-Sinai Medical Center

Publications -  50
Citations -  1629

Itai Danovitch is an academic researcher from Cedars-Sinai Medical Center. The author has contributed to research in topics: Randomized controlled trial & Quality of life. The author has an hindex of 16, co-authored 43 publications receiving 1080 citations. Previous affiliations of Itai Danovitch include University of California, Los Angeles & University of California.

Papers
More filters
Journal ArticleDOI

Cluster-Randomized Comparative Effectiveness Trial of Physician-Directed Clinical Decision Support vs. Patient-Directed Education to Promote Appropriate Use of Opioids for Chronic Pain.

TL;DR: In this article , the effectiveness of physician-directed clinical decision support (CDS) administered via electronic health record (EHR) vs. patient-directed education to promote appropriate use of opioids by conducting a cluster-randomized trial involving 82 primary care physicians and 951 of their patients with chronic pain.
Journal ArticleDOI

Pilot randomized controlled trial of a hospital-based substance use treatment and recovery team (START) to improve initiation of medication for alcohol or opioid use disorder and linkage to follow-up care.

TL;DR: A pilot randomized controlled trial (RCT) to explore whether a hospital inpatient addiction consult team (Substance Use Treatment and Recovery Team [START]) based on collaborative care was feasible, acceptable to patients, and whether it could improve uptake of medication in the hospital and linkage to care after discharge, as well as reduce substance use and hospital readmission as discussed by the authors .
Book ChapterDOI

Functional Assessment and Treatment of Alcohol Use Disorders

TL;DR: Natural molecular treatments—or functional treatments—are supported by several lines of evidence and may engage patients who are reluctant to accept pharmaceutical medications and foster nutritional health.
Journal Article

The Impact of Psilocybin on Patients Experiencing Psychiatric Symptoms: A Systematic Review of Randomized Clinical Trials.

TL;DR: In this paper , a systematic review aimed to evaluate the impact of psilocybin on patients experiencing psychiatric symptoms, with a focus on health-related quality of life (HRQoL) and safety.
Posted ContentDOI

Temporal Trends in Vaping Use: Demographic Diversity and Healthcare Utilization Outcomes

TL;DR: E-cigarettes use continues to expand, with evidence of racial/ethnic as well as geographic variation in uptake, and use of e-cigarette devices is associated with substantially higher rates of urgent healthcare utilization.